DAGNON TERRY (Chief Operating Officer) purchased 0.9% of their position (10K shares) of OUTLOOK THERAPEUTICS, INC. on the open market
Open‑market purchase worth $10.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/23/2022ACC: 0001209191-22-038989
Officer· Chief Operating Officer
Since Nov 2018
+10K
Net shares
Net buyer
$10.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$1.05
Trade value
$10.50K
% of position
0.9%
6/21/2022
1.16M→1.17M
Total
Net shares
+10K
Net value
$10.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2022 | P · Purchase | +10K | $1.05 | $10.50K | 0.9% | 1.16M | 1.17M |
| Total | +10K | $10.50K | ||||||
Derivative Transactions0
No derivative transactions reported